This paper reviews data reported in the literature as well as recent and un
published studies from our laboratory on the metabolism and genotoxicity of
the xenobiotic growth promoters 17 beta -trenbolone, melengestrol acetate
and zeranol. In our metabolic study, the oxidative in vitro metabolites gen
erated by hepatic microsomes from rats, bovine and humans were analyzed by
HPLC and GC/MS. 17 beta -Trenbolone gave rise to at least 13 monohydroxylat
ed products, whereas 12 mono- and dihydroxylated metabolites were obtained
with melengestrol acetate and at least 5 with zeranol. The genotoxic potent
ial of the parent compounds was studied using the following endpoints: indu
ction of HPRT mutations in cultured V79 cells and of lacI mutations in E. c
oli; induction of micronuclei in V79 cells; and formation of DNA adducts in
cultured primary rat hepatocytes. Negative results were obtained in most o
f these assay systems. Only the micronucleus induction was marginally posit
ive with 17 beta -trenbolone and zeranol at near-cytotoxic concentrations.
Commercial melengestrol acetate was found to contain an impurity causing ap
optosis in V79 cells. The genotoxic potential of the numerous oxidative met
abolites of the xenobiotic growth promoters remains to be studied.